TriSalus Life Sciences, Inc. TLSI Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.54M+116% | -$9.75M+9.8% | -$10.81M-30.4% | -$8.29M+20.1% | -$10.38M-2.6% | ||
| $135K+7.1% | $126K-22.7% | $163K-1.2% | $165K-4.1% | $172K-10.9% | ||
| $2.47M+12.5% | $2.2M-35.8% | $3.42M+80.9% | $1.89M+16.8% | $1.62M-4.5% | ||
| $296K+5.0% | $282K+2.5% | $275K+7.0% | $257K+9.4% | $235K+32.0% | ||
| -$1K+66.7% | -$3K— | —— | —— | -$117K-2,240% | ||
| -$1.29M-181% | $1.59M— | —— | $174K-52.5% | $366K+1.4% | ||
| $701K+452% | -$199K+62.5% | -$531K-49.6% | -$355K-411% | $114K+138% | ||
| $160K-76.9% | $692K-54.3% | $1.51M+184% | -$1.81M-211% | $1.62M— | ||
| $423K+320% | -$192K— | —— | -$266K+47.9% | -$511K— | ||
| $31K+40.9% | $22K-88.8% | $197K+432% | $37K-78.6% | $173K+458% | ||
| -$31K-14.8% | -$27K-3.8% | -$26K-4.0% | -$25K+55.4% | -$56K-40.0% | ||
| -$7.4M-244% | $5.15M+304% | -$2.52M-261% | -$700K-185% | $820K— | ||
| -$6.48M-161% | -$2.48M+33.0% | -$3.71M+49.3% | -$7.32M-62.7% | -$4.5M+21.2% | ||
| $141K+244% | $41K-81.0% | $216K— | —— | $754K+1,408% | ||
| $0— | —— | $40K— | —— | $40K— | ||
| -$141K-244% | -$41K+76.7% | -$176K— | —— | -$714K-1,328% | ||
| $42.63M— | —— | —— | $22.21M— | $0-100% | ||
| $9K+200% | $3K-50.0% | $6K+500% | $1K-98.6% | $71K+274% | ||
| $263K— | —— | —— | —— | $520K+7,329% | ||
| $42.39M+15,201% | $277K+238% | $82K-99.6% | $20.72M+114% | $9.69M+224% | ||
| $35.76M— | —— | —— | $13.49M+201% | $4.48M+262% | ||
| $1.14M-2.5% | $1.17M+20.4% | $971K+14.5% | $848K+19.6% | $709K— | ||
| $0— | —— | —— | $15K+1,400% | $1K-92.9% | ||
| $52K— | —— | —— | —— | $39K-16.6% | ||
| $296K+5.0% | $282K+2.5% | $275K+7.0% | $257K+9.4% | $235K+32.0% | ||
| -$7.4M-244% | $5.15M+304% | -$2.52M-261% | -$700K-185% | $820K— | ||
| $3.9M— | $0+100% | -$2.79M-484% | -$477K+42.9% | -$835K-42.5% | ||
| -$31K-14.8% | -$27K-3.8% | -$26K-4.0% | -$25K+55.4% | -$56K-40.0% | ||
| $423K+320% | -$192K— | —— | -$266K+47.9% | -$511K— | ||
| $31K+40.9% | $22K-88.8% | $197K+432% | $37K-78.6% | $173K+458% | ||
| $0— | —— | —— | —— | $266K+17.2% | ||
| $0— | —— | $40K— | —— | $40K— | ||
| $9K+200% | $3K-50.0% | $6K+500% | $1K-98.6% | $71K+274% | ||
| $263K— | —— | —— | —— | $520K+7,329% | ||
| —— | $101K0.0% | $101K0.0% | $101K0.0% | $101K-6.7% | ||
| $70K+1,300% | $5K-88.4% | $43K— | —— | $87K— | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| $0— | —— | —— | —— | $85K— | ||
| $0— | —— | —— | —— | $85K— | ||
| -$31K-14.8% | -$27K-3.8% | -$26K-4.0% | -$25K+55.4% | -$56K-40.0% | ||
| $0— | —— | —— | —— | $10M— | ||
| $57K— | —— | —— | —— | $0— | ||
| $0— | —— | —— | —— | -$366K-889% | ||
| $0— | —— | —— | $15K+1,400% | $1K-92.9% | ||
| -$6.62M-162% | -$2.53M+35.7% | -$3.93M+45.7% | -$7.23M-37.6% | -$5.25M+8.8% | ||
| -$6.62M-162% | -$2.53M+35.7% | -$3.93M+45.7% | -$7.23M-37.6% | -$5.25M+8.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does TriSalus Life Sciences, Inc. generate?
- TriSalus Life Sciences, Inc. (TLSI) generated -$20.0M in operating cash flow over the trailing twelve months.
- What is TriSalus Life Sciences, Inc.'s free cash flow?
- After $1.2M of capital expenditures, TriSalus Life Sciences, Inc.'s free cash flow was -$20.3M over the trailing twelve months, up 42.8% year over year.
- Where does TriSalus Life Sciences, Inc.'s cash flow data come from?
- Every line is extracted from TriSalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
